Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial) (Q73038843)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 October 2000
edit
Language Label Description Also known as
English
Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial)
scientific article published on 01 October 2000

    Statements

    Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial) (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit